Earnings PerformanceSTAA exceeded first quarter revenue expectations with strong sales, reflecting disciplined control on operating expenses and positive adjusted EBITDA.
Financial GuidanceSTAAR's confidence is underscored by raising its full-year revenue guidance to the higher end of previous estimates, signaling anticipated strong performance and robust financial health.
Market GrowthSurgeons report growing demand for refractive procedures, indicating a potential increase in market share for STAA's ICL products as they gain popularity over traditional options like LASIK.